Quantbot Technologies LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$94,923
+578.0%
1,421
+1444.6%
0.01%
+600.0%
Q4 2021$14,000
+250.0%
92
+187.5%
0.00%
Q3 2021$4,000
-94.6%
32
-95.9%
0.00%
-100.0%
Q3 2020$74,000
+428.6%
780
+486.5%
0.01%
+300.0%
Q2 2020$14,000133
+1377.8%
0.00%
Q1 2020$0
-100.0%
9
-98.7%
0.00%
-100.0%
Q4 2019$73,000
-49.3%
705
-51.3%
0.01%
-50.0%
Q3 2019$144,000
+1100.0%
1,447
+1347.0%
0.01%
+1300.0%
Q1 2019$12,000
-95.8%
100
-95.3%
0.00%
-96.4%
Q4 2018$289,000
+556.8%
2,137
+410.0%
0.03%
+460.0%
Q1 2017$44,000
-90.6%
419
-90.9%
0.01%
-90.4%
Q3 2016$467,000
+2235.0%
4,581
+2190.5%
0.05%
+1200.0%
Q2 2015$20,000
-60.0%
200
-78.9%
0.00%
-75.0%
Q4 2014$50,000
-31.5%
949
-13.7%
0.02%
-5.9%
Q1 2014$73,000
+1360.0%
1,100
+1000.0%
0.02%
+750.0%
Q4 2013$5,0001000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders